Borden E - Search Results

1

Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.

Budd GT, Cristofanilli M, Ellis MJ, Stopeck A, Borden E, Miller MC, Matera J, Repollet M, Doyle GV, Terstappen LW, Hayes DF. Budd GT, et al. Among authors: borden e. Clin Cancer Res. 2006 Nov 1;12(21):6403-9. doi: 10.1158/1078-0432.CCR-05-1769. Clin Cancer Res. 2006. PMID: 17085652 Clinical Trial.

2

A phase I study of sunitinib plus bevacizumab in advanced solid tumors.

Rini BI, Garcia JA, Cooney MM, Elson P, Tyler A, Beatty K, Bokar J, Mekhail T, Bukowski RM, Budd GT, Triozzi P, Borden E, Ivy P, Chen HX, Dolwati A, Dreicer R. Rini BI, et al. Among authors: borden e. Clin Cancer Res. 2009 Oct 1;15(19):6277-83. doi: 10.1158/1078-0432.CCR-09-0717. Epub 2009 Sep 22. Clin Cancer Res. 2009. PMID: 19773375 Free PMC article. Clinical Trial.

3

Intimal pulmonary artery sarcoma presenting as dyspnea: case report.

Hsing JM, Thakkar SG, Borden EC, Budd GT. Hsing JM, et al. Int Semin Surg Oncol. 2007 Jun 29;4:14. doi: 10.1186/1477-7800-4-14. Int Semin Surg Oncol. 2007. PMID: 17603895 Free PMC article.

4

Phase I trial of consensus interferon in patients with metastatic renal cell carcinoma: toxicity and immunological effects.

Hutson TE, Molto L, Mekhail T, Elson P, Finke J, Tannenbaum C, Borden E, Dreicer R, Olencki T, Bukowski RM. Hutson TE, et al. Among authors: borden e. Clin Cancer Res. 2003 Apr;9(4):1354-60. Clin Cancer Res. 2003. PMID: 12684404 Clinical Trial.

5

Soft tissue sarcomas of adults: state of the translational science.

Borden EC, Baker LH, Bell RS, Bramwell V, Demetri GD, Eisenberg BL, Fletcher CD, Fletcher JA, Ladanyi M, Meltzer P, O'Sullivan B, Parkinson DR, Pisters PW, Saxman S, Singer S, Sundaram M, van Oosterom AT, Verweij J, Waalen J, Weiss SW, Brennan MF. Borden EC, et al. Clin Cancer Res. 2003 Jun;9(6):1941-56. Clin Cancer Res. 2003. PMID: 12796356 Review.

6

Enrichment of circulating melanoma cells (CMCs) using negative selection from patients with metastatic melanoma.

Joshi P, Jacobs B, Derakhshan A, Moore LR, Elson P, Triozzi PL, Borden E, Zborowski M. Joshi P, et al. Among authors: borden e. Oncotarget. 2014 May 15;5(9):2450-61. doi: 10.18632/oncotarget.1683. Oncotarget. 2014. PMID: 24811334 Free PMC article.

7

Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines.

Chawla-Sarkar M, Leaman DW, Borden EC. Chawla-Sarkar M, et al. Among authors: borden ec. Clin Cancer Res. 2001 Jun;7(6):1821-31. Clin Cancer Res. 2001. PMID: 11410525

8

Expression of RASSF1A, an epigenetically silenced tumor suppressor, overcomes resistance to apoptosis induction by interferons.

Reu FJ, Leaman DW, Maitra RR, Bae SI, Cherkassky L, Fox MW, Rempinski DR, Beaulieu N, MacLeod AR, Borden EC. Reu FJ, et al. Cancer Res. 2006 Mar 1;66(5):2785-93. doi: 10.1158/0008-5472.CAN-05-2303. Cancer Res. 2006. PMID: 16510600 Free PMC article.

9

Prevalence of circulating tumor cells in localized prostate cancer.

Khurana KK, Grane R, Borden EC, Klein EA. Khurana KK, et al. Curr Urol. 2013 Nov;7(2):65-9. doi: 10.1159/000356251. Epub 2013 Oct 30. Curr Urol. 2013. PMID: 24917761 Free PMC article.

10

Metastatic uveal melanoma.

Singh AD, Borden EC. Singh AD, et al. Ophthalmol Clin North Am. 2005 Mar;18(1):143-50, ix. doi: 10.1016/j.ohc.2004.07.003. Ophthalmol Clin North Am. 2005. PMID: 15763199 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

351 results

Search Page

Filters